biote Corp
biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with … Read more
biote Corp (BTMD) - Total Assets
Latest total assets as of September 2025: $111.32 Million USD
Based on the latest financial reports, biote Corp (BTMD) holds total assets worth $111.32 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
biote Corp - Total Assets Trend (2019–2024)
This chart illustrates how biote Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
biote Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
biote Corp's total assets of $111.32 Million consist of 55.7% current assets and 44.3% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 32.2% |
| Accounts Receivable | $7.70 Million | 6.3% |
| Inventory | $14.85 Million | 12.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $9.38 Million | 7.7% |
| Goodwill | $5.83 Million | 4.8% |
Asset Composition Trend (2019–2024)
This chart illustrates how biote Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: biote Corp's current assets represent 55.7% of total assets in 2024, a decrease from 80.8% in 2019.
- Cash Position: Cash and equivalents constituted 32.2% of total assets in 2024, down from 43.9% in 2019.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 7.0% in 2019.
- Asset Diversification: The largest asset category is inventory at 12.1% of total assets.
biote Corp Competitors by Total Assets
Key competitors of biote Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Xian International Medical Investment Co Ltd
SHE:000516
|
China | CN¥9.79 Billion |
|
Meinian Onehealth Healthcare Holdings Co Ltd
SHE:002044
|
China | CN¥19.57 Billion |
|
Hengkang Medical Group Co Ltd
SHE:002219
|
China | CN¥6.55 Billion |
|
TMC Life Sciences Bhd
KLSE:0101
|
Malaysia | RM1.12 Billion |
|
Optimax Holdings Sdn Bhd
KLSE:0222
|
Malaysia | RM146.00 Million |
|
Cengild Medical Berhad
KLSE:0243
|
Malaysia | RM218.07 Million |
|
DC HEALTHCARE HOLDINGS BERHAD
KLSE:0283
|
Malaysia | RM99.33 Million |
|
Raffles Medical Group Ltd
F:02M1
|
Germany | €1.49 Billion |
biote Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - biote Corp generates 1.61x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, biote Corp generates $ 2.58 in net profit.
biote Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.01 | 1.50 | 2.38 |
| Quick Ratio | 0.72 | 1.16 | 2.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $815.00K | $ 23.47 Million | $ 16.11 Million |
biote Corp - Advanced Valuation Insights
This section examines the relationship between biote Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.96 |
| Latest Market Cap to Assets Ratio | 0.24 |
| Asset Growth Rate (YoY) | -21.2% |
| Total Assets | $122.37 Million |
| Market Capitalization | $29.09 Million USD |
Valuation Analysis
Below Book Valuation: The market values biote Corp's assets below their book value (0.24 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: biote Corp's assets decreased by 21.2% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for biote Corp (2019–2024)
The table below shows the annual total assets of biote Corp from 2019 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $122.37 Million | -21.20% |
| 2023-12-31 | $155.29 Million | +39.10% |
| 2022-12-31 | $111.64 Million | +105.49% |
| 2021-12-31 | $54.33 Million | +66.72% |
| 2020-12-31 | $32.59 Million | +36.40% |
| 2019-12-31 | $23.89 Million | -- |